Hestia Insight Inc. announced its appointment of an additional advisory board member to assist in the growth of the Company. Dr. T.Z. (Ted) Chaung, a seasoned independent healthcare consultant with broad experience in healthcare industry startups, new drug development, venture capital, and business development, in both the Taiwan and U.S. healthcare sectors, has joined the Company's advisory board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.16 USD | +45.47% | 0.00% | -36.00% |
Apr. 22 | Hestia Insight Inc. Reports Earnings Results for the First Quarter Ended February 29, 2024 | CI |
Mar. 14 | Hestia Insight Inc. Reports Earnings Results for the Full Year Ended November 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-36.00% | 4.47M | |
+10.77% | 50.27B | |
+27.30% | 13.79B | |
+27.11% | 7.72B | |
-1.49% | 7.24B | |
+9.99% | 6.54B | |
-14.63% | 2.88B | |
+26.04% | 2.11B | |
+20.97% | 1.98B | |
+6.42% | 1.33B |
- Stock Market
- Equities
- HSTA Stock
- News Hestia Insight Inc.
- Hestia Insight Inc. Appoints T.Z. Chaung as Advisory Board Member